Manufacturer record

Alexa Pharmaceuticals: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

7 batches manufactured by Alexa Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between August 2024 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: ABT25838, Amoxycillin Potassium Clavulanate & Lactic Acid Bacillus Tablets (exp Aug 2027). SDTL, Andhra Pradesh, Vijayawada (state lab) found it not of standard quality: Identification & Assay of Clavulanic Acid and Assay of Amoxycillin. Listed in the September 2026 alert.

Records by type

7 records linked to Alexa Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
7Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Aug 2024 to Sep 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

7
NSQ batches since 2024
6
Products affected
Assay
Most common failure
Sep 2026
Latest alert

Flagged batches per year

2024 · 12025 · 52026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Amoxycillin Potassium Clavulanate & Lactic Acid Bacillus Tablets Batch ABT25838Mfg Mar 2026 · Exp Aug 2027 Identification & Assay of Clavulanic Acid and Assay of AmoxycillinAssay SDTL, Andhra Pradesh, VijayawadaState lab Sep 2026
Amoxycilin, Clavulanic Acid (Kaiclav-625 LB) Batch ABT24350Mfg Oct 2024 · Exp Mar 2026 Content of Amoxycillin and Clavulanic acidOther SDT&RL, BhubaneswarState lab Dec 2025
Ampicillin Trihydrate & Bromhexine Hydrochloride Capsules Batch ABC24006Mfg Apr 2024 · Exp Mar 2026 Assay of Ampicillin Trihydrate and Bromhexine Hydrochloride.Assay RDTL, GuwahatiCDSCO lab Aug 2025
Ampicillin Trihydrate & Bromhexine Hydrochloride Capsules Batch ABC240032Mfg Oct 2024 · Exp Sep 2026 Assay of Bromhexine Hydrochloride and Ampicillin Trihydrate.Assay RDTL, GuwahatiCDSCO lab Aug 2025
Amoxycillin& Potassium Clavulanate Tablets I.P (AMOXMED ? CV 625 Tablets) Batch ABT24071Mfg May 2024 · Exp Oct 2025 The sample does not conform to standard quality in respect of the test for Dissolution & AssayAssay State Drugs Testing Laboratory, Agartala, TripuraState lab May 2025
Acremox-500 (Amoxycillin Trihydrate & Lactic Acid Bacillus Capsules) Batch ABC24002Mfg Apr 2024 · Exp Mar 2026 Assay for AmoxycillinAssay State Lab KarnatakaState lab Apr 2025
Moxymed CV Batch ABT 23316Mfg Nov 2023 · Exp Apr 2025 The content of Amoxycillin and Clavulanic acid is not with in the limits of schedule ?V? of Drugs and Cosmetics Act & Rules as mentioned in the Laboratory protocolOther DTL ThiruvananthapuramState lab Aug 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.